vyne stock forecast zacks

VYNE Stock Price Prediction. Zacks Investment Research upgraded shares of VYNE Therapeutics NASDAQVYNE from a sell rating to a hold rating in a report published on Thursday morning.

Vyne Therapeutics Inc Vyne May Report Negative Earnings Know The Trend Ahead Of Q1 Release April 28 2022 Zacks Com

View VYNE Therapeutics VYNE investment stock information.

. Get the latest VYNE Therapeutics VYNE detailed stock quotes stock data Real-Time ECN charts stats and more. The 3 analysts offering 12-month price forecasts for Vyne Therapeutics Inc have a median target of 400 with a high estimate of 500 and a low estimate of 150. The average price target is.

Sentiment analysis fundamental analysis financials web traffic data economic data analyst opinions hedge fund trading analysis competitor analysis search data. Get a real-time VYNE Therapeutics Inc. Real-time trade and investing ideas on VYNE Therapeutics Inc VYNE from the largest community of traders and investors.

Rooms Rankings Earnings Newsletters. 48685 Upside Based on 2 Wall Street analysts offering 12 month price targets for VYNE Therapeutics in the last 3 months. VYNE stock price quote with breaking news financials statistics charts and more.

Stock Price Forecast. If a stocks EPS consensus estimate is 110 now vs. 100 the week before that.

Its an integral part of the Zacks Rank and a critical part in effective stock evaluation. According to 12 stock analysts the average 12-month stock price forecast for VYNE stock is 479 which predicts an increase of 180989.

Do Options Traders Know Something About Vyne Therapeutics Vyne Stock We Don T